taurine has been researched along with Blood Pressure, High in 79 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our objective was to determine the effectiveness of a perindopril/indapamide (Per/Ind) single-pill combination (SPC) in a broad range of patient profiles, including subgroups with varying hypertension severity, age and cardiovascular risk profiles." | 8.02 | Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies. ( Brzozowska-Villatte, R; Dézsi, CA; Farsang, C; Glezer, M; Karpov, Y, 2021) |
| "To elucidate the synergistic effects of taurine and L-arginine on hypertension, 25% fructose were administered to male Wistar rats for 3 months to establish insulin resistance hypertensive models." | 7.79 | Synergistic effects of taurine and L-arginine on attenuating insulin resistance hypertension. ( Feng, Y; Gao, Y; Hu, J; Li, J; Lv, Q; Yang, J; Yang, Q, 2013) |
| "Fructose-induced hypertension was used to test the hypothesis that taurine supplementation and/or exercise can prevent hypertension and increase exercise capacity." | 7.77 | Taurine prevents hypertension and increases exercise capacity in rats with fructose-induced hypertension. ( Go, HK; Hong, CU; Kang, HS; Kim, GB; Kim, JS; Kim, SJ; Kim, SZ; Lee, YU; Park, HM; Rahman, MM, 2011) |
| "Taurine is known to lower blood pressure in essential hypertension and some experimental hypertensive models." | 7.70 | Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats. ( Harada, H; Hayashi, T; Iwata, S; Kitazaki, K; Morimoto, K; Nonaka, H; Takeshita, T; Tsujino, T; Watari, Y; Yokoyama, M, 2000) |
| "Administration of taurine (3% in drinking water) for 4 weeks retarded the development of salt (4% sodium chloride diet)-induced hypertension." | 7.69 | Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. ( Arakawa, K; Ideishi, M; Misumi, Y; Miura, S; Sakai, T; Sasaguri, M, 1994) |
| "To study the antihypertensive effect of orally administered taurine in DOCA salt hypertension, urinary excretion of catecholamines, electrolytes, and arg-vasopressin was measured over four weeks in 20 taurine treated DOCA rats (group 1), 20 taurine untreated DOCA rats (group 2), and seven taurine untreated sham operated rats (group 3)." | 7.67 | Retardation of the development of hypertension in DOCA salt rats by taurine supplement. ( Inoue, A; Kohno, Y; Lee, LC; Nakagawa, M; Sasaki, S; Takahashi, H; Takeda, K; Yoshimura, M, 1988) |
| "In order to evaluate how taurine relates to the pathogenesis of essential hypertension, the taurine content of plasma, whole blood and urine was measured in 18 normals and in 79 hypertensive patients." | 7.66 | Decrease of urinary taurine in essential hypertension. ( Katori, R; Kohashi, N, 1983) |
| "The content of taurine in the hypertrophied left ventricle is increased in congestive heart failure an in spontaneously hypertensive (SH) rats." | 7.66 | Platelet taurine in patients with arterial hypertension, myocardial failure or infarction. ( Himberg, JJ; Paasonen, MK; Penttilä, O; Solatunturi, E, 1980) |
| "The concentration of taurine in the left ventricular muscle of hearts of patients who died of chronic congestive heart failure was twice that of patients who died of other causes and had no cardiac pathology." | 7.65 | Taurine concentrations in congestive heart failure. ( Bressler, R; Huxtable, R, 1974) |
| "Oral taurine treatment has been studied extensively as a hypotensive agent." | 6.41 | Treatment of hypertension with oral taurine: experimental and clinical studies. ( Lombardini, JB; Militante, JD, 2002) |
| "Taurine (T) was first noted as beneficial for stroke and cardiovascular diseases (CVD) prevention in genetic rat models, stroke-prone spontaneously hypertensive rats (SHRSP)." | 4.86 | Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. ( Hamada, A; Kunimasa, K; Mori, H; Mori, M; Taguchi, T; Yamori, Y, 2010) |
| " The combination of uninephrectomy, taurine-deficiency and high-salt intake led to arterial hypertension." | 4.12 | Experimental uninephrectomy associates with less parasympathetic modulation of heart rate and facilitates sodium-dependent arterial hypertension. ( Brandes, RP; Pliquett, RU, 2022) |
| "Our objective was to determine the effectiveness of a perindopril/indapamide (Per/Ind) single-pill combination (SPC) in a broad range of patient profiles, including subgroups with varying hypertension severity, age and cardiovascular risk profiles." | 4.02 | Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies. ( Brzozowska-Villatte, R; Dézsi, CA; Farsang, C; Glezer, M; Karpov, Y, 2021) |
| "The beneficial health effects of taurine on hypertension have been demonstrated previously in both experimental and epidemiological studies." | 3.88 | Taurine enhances spermatogenic function and antioxidant defense mechanisms in testes and epididymis of L-NAME-induced hypertensive rats. ( Adedara, IA; Adeyemo, MO; Ajibade, TO; Alake, SE; Farombi, EO; Olajide, LO, 2018) |
| " The widely distributed amino acid taurine seems to be an effective depressor agent in drug-induced hypertension." | 3.83 | Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats. ( Badiu, C; Căruntu, C; Gaman, L; Iosif, L; Mirica, R; Popescu, BO; Roşca, AE; Stancu, CS; Stoian, I; Tivig, IC; Voiculescu, SE; Zăgrean, L, 2016) |
| "To elucidate the synergistic effects of taurine and L-arginine on hypertension, 25% fructose were administered to male Wistar rats for 3 months to establish insulin resistance hypertensive models." | 3.79 | Synergistic effects of taurine and L-arginine on attenuating insulin resistance hypertension. ( Feng, Y; Gao, Y; Hu, J; Li, J; Lv, Q; Yang, J; Yang, Q, 2013) |
| "Fructose-induced hypertension was used to test the hypothesis that taurine supplementation and/or exercise can prevent hypertension and increase exercise capacity." | 3.77 | Taurine prevents hypertension and increases exercise capacity in rats with fructose-induced hypertension. ( Go, HK; Hong, CU; Kang, HS; Kim, GB; Kim, JS; Kim, SJ; Kim, SZ; Lee, YU; Park, HM; Rahman, MM, 2011) |
| "In fawn-hooded hypertensive (FHH) rats, a model of hypertension, impaired preglomerular resistance, hyperfiltration, and progressive renal injury, we recently observed that supporting perinatal nitric oxide (NO) availability with the NO donor molsidomine persistently reduced blood pressure (BP) and ameliorated renal injury in male and female offspring." | 3.76 | Perinatal micronutrient supplements ameliorate hypertension and proteinuria in adult fawn-hooded hypertensive rats. ( Braam, B; Goldschmeding, R; Joles, JA; Koeners, MP; van der Giezen, DM, 2010) |
| "To investigate the effect of taurine on hypertension, a rat model of hypertension was produced by administering N-nitro-L-arginine methylester (L-NAME) to reduce the levels of the vasodilator, nitric oxide." | 3.75 | Antihypertensive effect of taurine in rat. ( Hu, J; Lv, Q; Sun, C; Wu, G; Xu, X; Yang, J, 2009) |
| "Taurine is known to lower blood pressure in essential hypertension and some experimental hypertensive models." | 3.70 | Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats. ( Harada, H; Hayashi, T; Iwata, S; Kitazaki, K; Morimoto, K; Nonaka, H; Takeshita, T; Tsujino, T; Watari, Y; Yokoyama, M, 2000) |
| "Administration of taurine (3% in drinking water) for 4 weeks retarded the development of salt (4% sodium chloride diet)-induced hypertension." | 3.69 | Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. ( Arakawa, K; Ideishi, M; Misumi, Y; Miura, S; Sakai, T; Sasaguri, M, 1994) |
| "To study the antihypertensive effect of orally administered taurine in DOCA salt hypertension, urinary excretion of catecholamines, electrolytes, and arg-vasopressin was measured over four weeks in 20 taurine treated DOCA rats (group 1), 20 taurine untreated DOCA rats (group 2), and seven taurine untreated sham operated rats (group 3)." | 3.67 | Retardation of the development of hypertension in DOCA salt rats by taurine supplement. ( Inoue, A; Kohno, Y; Lee, LC; Nakagawa, M; Sasaki, S; Takahashi, H; Takeda, K; Yoshimura, M, 1988) |
| "In order to evaluate the correlation between sulfur amino acids (derived mainly form animal protein in the diet) and blood pressure, free amino acids, including sulfur amino acids such as taurine and methionine, were determined in the plasma and cerebrospinal fluid (CSF) of twelve normotensive subjects and twelve patients with essential hypertension under nutritional control after at least 10 days of standard hospital diet (total calorie and protein content: 2100-2300 Cal per day and 78-83 g per day, respectively)." | 3.67 | Decrease of plasma sulfur amino acids in essential hypertension. ( Ishijima, M; Ogawa, M; Takahara, A; Tazaki, S, 1985) |
| "In order to evaluate how taurine relates to the pathogenesis of essential hypertension, the taurine content of plasma, whole blood and urine was measured in 18 normals and in 79 hypertensive patients." | 3.66 | Decrease of urinary taurine in essential hypertension. ( Katori, R; Kohashi, N, 1983) |
| "The content of taurine in the hypertrophied left ventricle is increased in congestive heart failure an in spontaneously hypertensive (SH) rats." | 3.66 | Platelet taurine in patients with arterial hypertension, myocardial failure or infarction. ( Himberg, JJ; Paasonen, MK; Penttilä, O; Solatunturi, E, 1980) |
| "The concentration of taurine in the left ventricular muscle of hearts of patients who died of chronic congestive heart failure was twice that of patients who died of other causes and had no cardiac pathology." | 3.65 | Taurine concentrations in congestive heart failure. ( Bressler, R; Huxtable, R, 1974) |
| "Taurine is an abundant, free amino acid found in mammalian cells that contributes to many physiologic functions from that of a simple cell osmolyte to a programmer of adult health and disease." | 2.50 | Perinatal taurine exposure affects adult arterial pressure control. ( Roysommuti, S; Wyss, JM, 2014) |
| "Oral taurine treatment has been studied extensively as a hypotensive agent." | 2.41 | Treatment of hypertension with oral taurine: experimental and clinical studies. ( Lombardini, JB; Militante, JD, 2002) |
| "Hypertension has also been reported to be associated with low physical fitness in cross-sectional studies." | 2.38 | [Health and exercise: effects of exercise on high blood pressure]. ( Himeno, E; Ikeda, M; Nanri, H, 1993) |
| "Hypertension is the largest risk factor affecting global mortality." | 1.91 | Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites. ( Chakraborty, S; Cheng, X; Golonka, RM; Jia, W; Joe, B; Lulla, A; Mandal, J; Mei, X; Mell, B; Meyer, K; Piyarathna, DWB; Putluri, N; Putluri, V; Saha, P; Sreekumar, A; Vijay-Kumar, M; Yang, T; Yeo, JY; Yeoh, BS, 2023) |
| "Taurine plays an important role in the modulation of cardiovascular function by acting not only within the brain but also within peripheral tissues." | 1.51 | Taurine Regulation of Peripheral Hemodynamics. ( El Idrissi, A; Sidime, F, 2019) |
| "Hypertension was induced by oral administration of nitric oxide synthase inhibitor, N-nitro L-arginine-methyl-ester (L-NAME), at 40 mg/kg body weight to the male Wistar rats for 14 consecutive days." | 1.51 | Taurine Ameliorates Thyroid Hypofunction and Renal Injury in L-NAME-Induced Hypertensive Rats. ( Adedara, IA; Adeyemo, MO; Ajibade, TO; Alake, SE; Farombi, EO; Olajide, LO, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (45.57) | 18.7374 |
| 1990's | 12 (15.19) | 18.2507 |
| 2000's | 14 (17.72) | 29.6817 |
| 2010's | 12 (15.19) | 24.3611 |
| 2020's | 5 (6.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pliquett, RU | 1 |
| Brandes, RP | 1 |
| Belcaro, G | 1 |
| Cox, DM | 1 |
| Cesarone, MR | 1 |
| Scipione, C | 1 |
| Scipione, V | 1 |
| Dugall, M | 1 |
| Corsi, M | 1 |
| Feragalli, B | 1 |
| Cotellese, R | 1 |
| Oliaro, E | 1 |
| Yildiz, O | 1 |
| Ulusoy, KG | 1 |
| Chakraborty, S | 1 |
| Lulla, A | 1 |
| Cheng, X | 1 |
| Yeo, JY | 1 |
| Mandal, J | 1 |
| Yang, T | 1 |
| Mei, X | 1 |
| Saha, P | 1 |
| Golonka, RM | 1 |
| Yeoh, BS | 1 |
| Mell, B | 1 |
| Jia, W | 1 |
| Putluri, V | 1 |
| Piyarathna, DWB | 1 |
| Putluri, N | 1 |
| Sreekumar, A | 1 |
| Meyer, K | 1 |
| Vijay-Kumar, M | 1 |
| Joe, B | 1 |
| Sidime, F | 1 |
| El Idrissi, A | 1 |
| Dézsi, CA | 1 |
| Glezer, M | 1 |
| Karpov, Y | 1 |
| Brzozowska-Villatte, R | 1 |
| Farsang, C | 1 |
| Adedara, IA | 2 |
| Alake, SE | 2 |
| Adeyemo, MO | 2 |
| Olajide, LO | 2 |
| Ajibade, TO | 2 |
| Farombi, EO | 2 |
| Lv, Q | 3 |
| Dong, G | 1 |
| Cao, S | 1 |
| Wu, G | 2 |
| Feng, Y | 2 |
| Mei, L | 1 |
| Lin, S | 1 |
| Yang, Q | 2 |
| Yang, J | 3 |
| Hu, J | 3 |
| Roşca, AE | 1 |
| Stoian, I | 1 |
| Badiu, C | 1 |
| Gaman, L | 1 |
| Popescu, BO | 1 |
| Iosif, L | 1 |
| Mirica, R | 1 |
| Tivig, IC | 1 |
| Stancu, CS | 1 |
| Căruntu, C | 1 |
| Voiculescu, SE | 1 |
| Zăgrean, L | 1 |
| Hilfiker, MA | 1 |
| Zhang, D | 1 |
| Dowdell, SE | 1 |
| Goodman, KB | 1 |
| McAtee, JJ | 1 |
| Dodson, JW | 1 |
| Viet, AQ | 1 |
| Wang, GZ | 1 |
| Sehon, CA | 1 |
| Behm, DJ | 1 |
| Wu, Z | 1 |
| Carballo, LH | 1 |
| Douglas, SA | 1 |
| Neeb, MJ | 1 |
| Xu, X | 1 |
| Sun, C | 1 |
| Roysommuti, S | 2 |
| Suwanich, A | 1 |
| Jirakulsomchok, D | 1 |
| Wyss, JM | 2 |
| Akira, K | 3 |
| Mitome, H | 2 |
| Imachi, M | 3 |
| Shida, Y | 1 |
| Miyaoka, H | 1 |
| Hashimoto, T | 3 |
| Koeners, MP | 1 |
| Braam, B | 1 |
| van der Giezen, DM | 1 |
| Goldschmeding, R | 1 |
| Joles, JA | 1 |
| Yamori, Y | 11 |
| Taguchi, T | 1 |
| Hamada, A | 1 |
| Kunimasa, K | 1 |
| Mori, H | 1 |
| Mori, M | 1 |
| Rahman, MM | 1 |
| Park, HM | 1 |
| Kim, SJ | 1 |
| Go, HK | 1 |
| Kim, GB | 1 |
| Hong, CU | 1 |
| Lee, YU | 1 |
| Kim, SZ | 1 |
| Kim, JS | 1 |
| Kang, HS | 1 |
| Masu, S | 1 |
| Li, J | 1 |
| Gao, Y | 1 |
| Militante, JD | 1 |
| Lombardini, JB | 1 |
| Mozaffari, MS | 2 |
| Miyata, N | 1 |
| Schaffer, SW | 2 |
| KNAUFF, HG | 1 |
| GOTTSTEIN, U | 1 |
| MILLER, B | 1 |
| Harada, H | 2 |
| Tsujino, T | 2 |
| Watari, Y | 2 |
| Nonaka, H | 2 |
| Emoto, N | 1 |
| Yokoyama, M | 2 |
| Nandhini, AT | 1 |
| Anuradha, CV | 2 |
| Hagar, HH | 1 |
| El Etter, E | 1 |
| Arafa, M | 1 |
| Abdelsayed, R | 1 |
| Patel, C | 1 |
| Fujita, T | 7 |
| Sato, Y | 6 |
| Chau, C | 1 |
| Heu, P | 1 |
| Chou, SC | 1 |
| Miyahara, JT | 1 |
| Ramanathan, S | 1 |
| Katori, R | 3 |
| Kohashi, N | 3 |
| Okabayashi, T | 2 |
| Lovenberg, W | 3 |
| Kuriyama, K | 2 |
| Ida, S | 2 |
| Ohkuma, S | 2 |
| Lilequist, R | 1 |
| Paasonen, MK | 4 |
| Solatunturi, E | 4 |
| Hama, J | 1 |
| Penttilä, O | 1 |
| Himberg, JJ | 1 |
| Liljequist, R | 1 |
| Nakagawa, M | 3 |
| Takeda, K | 3 |
| Yoshitomi, T | 1 |
| Itoh, H | 1 |
| Nakata, T | 1 |
| Sasaki, S | 3 |
| Ideishi, M | 1 |
| Miura, S | 1 |
| Sakai, T | 1 |
| Sasaguri, M | 1 |
| Misumi, Y | 1 |
| Arakawa, K | 3 |
| Ikeda, M | 2 |
| Nanri, H | 1 |
| Himeno, E | 1 |
| Murakami, S | 1 |
| Yamagishi, I | 1 |
| Asami, Y | 1 |
| Ohta, Y | 1 |
| Toda, Y | 1 |
| Nara, Y | 8 |
| Elizarova, EP | 1 |
| Ikeda, K | 3 |
| Mizushima, S | 2 |
| Balakrishnan, SD | 1 |
| Kitazaki, K | 1 |
| Iwata, S | 1 |
| Hayashi, T | 1 |
| Takeshita, T | 1 |
| Morimoto, K | 1 |
| Liu, L | 1 |
| Hattori, H | 1 |
| Miura, A | 1 |
| Gao, M | 1 |
| Dawson, R | 1 |
| Liu, S | 1 |
| Jung, B | 1 |
| Messina, S | 1 |
| Eppler, B | 1 |
| Huxtable, R | 2 |
| Chubb, J | 1 |
| Bressler, R | 2 |
| Horie, R | 3 |
| Ohtaka, M | 2 |
| Ooshima, A | 2 |
| Sasagawa, S | 1 |
| Iritani, N | 1 |
| Trabattoni, P | 1 |
| Gerloni, A | 1 |
| Ando, K | 3 |
| Ooboshi, H | 1 |
| Yao, H | 1 |
| Matsumoto, T | 1 |
| Hirano, M | 1 |
| Uchimura, H | 1 |
| Sadoshima, S | 1 |
| Fujishima, M | 1 |
| Ogata, E | 1 |
| Otani, F | 1 |
| Ejiri, K | 1 |
| Akahori, S | 1 |
| Kanemori, H | 1 |
| Kudo, T | 1 |
| Sekiba, K | 1 |
| Kubo, T | 1 |
| Kihara, M | 1 |
| Misu, Y | 1 |
| Tanabe, Y | 1 |
| Urata, H | 1 |
| Kiyonaga, A | 1 |
| Tanaka, H | 1 |
| Shindo, M | 1 |
| Hamlin, RL | 1 |
| Buffington, CA | 1 |
| Inoue, A | 2 |
| Takahashi, H | 2 |
| Lee, LC | 2 |
| Kohno, Y | 1 |
| Yoshimura, M | 2 |
| Abe, M | 1 |
| Shibata, K | 1 |
| Matsuda, T | 1 |
| Furukawa, T | 1 |
| Sawamura, M | 1 |
| Mano, M | 1 |
| Ogawa, M | 2 |
| Noda, H | 1 |
| Ito, Y | 1 |
| Ijichi, H | 1 |
| Takahara, A | 1 |
| Ishijima, M | 1 |
| Tazaki, S | 1 |
| Nieminen, ML | 1 |
| Tanaka, Y | 1 |
| De Lorenzi, F | 1 |
| Calabrese, L | 1 |
| Montagnani, I | 1 |
9 reviews available for taurine and Blood Pressure, High
| Article | Year |
|---|---|
Effects of taurine on vascular tone.
Topics: Animals; Blood Pressure; Endothelium, Vascular; Humans; Hypertension; Mammals; Potassium Channels; T | 2022 |
Taurine in health and diseases: consistent evidence from experimental and epidemiological studies.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Cholesterol, Dietary; Diet; Dietary Fats; Humans; | 2010 |
Perinatal taurine exposure affects adult arterial pressure control.
Topics: Adult; Animals; Blood Pressure; Epigenesis, Genetic; Female; Glucose; Humans; Hypertension; Insulin; | 2014 |
Treatment of hypertension with oral taurine: experimental and clinical studies.
Topics: Administration, Oral; Animals; Blood Pressure; Central Nervous System; Disease Models, Animal; Human | 2002 |
[Health and exercise: effects of exercise on high blood pressure].
Topics: Adenosine Triphosphate; Catecholamines; Electrolytes; Energy Metabolism; Exercise Therapy; Humans; H | 1993 |
Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition?
Topics: Animals; Arteriosclerosis; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Diso | 1996 |
Taurine involvement in retinal and heart muscle function.
Topics: Amino Acids, Sulfur; Animals; Cats; Cysteine; Deficiency Diseases; Heart; Heart Failure; Humans; Hyp | 1975 |
[Etiological and physiopathological significance of taurine in hypertension].
Topics: Animals; Blood Pressure; Endorphins; Humans; Hypertension; Parasympathetic Nervous System; Sympathet | 1992 |
Nutrition and the heart.
Topics: Animals; Cachexia; Carnitine; Cat Diseases; Cats; Diet; Dog Diseases; Dogs; Heart Diseases; Heart Fa | 1989 |
1 trial available for taurine and Blood Pressure, High
| Article | Year |
|---|---|
Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension.
Topics: Adrenal Medulla; Adult; Blood Pressure; Double-Blind Method; Epinephrine; Glucagon; Humans; Hyperten | 1987 |
69 other studies available for taurine and Blood Pressure, High
| Article | Year |
|---|---|
Experimental uninephrectomy associates with less parasympathetic modulation of heart rate and facilitates sodium-dependent arterial hypertension.
Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Heart Rate; Hypertension; Mice; Sodium; Sodium | 2022 |
Soft management of borderline hypertension: blood pressure, endothelial function, oxidative stress. The GSACE-YOMFO registry (Grape Seeds, 2-ACEs, Yoga-Meditation, Fish oil).
Topics: Blood Pressure; Fish Oils; Hypertension; Meditation; Oxidative Stress; Registries; Stress, Psycholog | 2022 |
Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites.
Topics: Animals; Antihypertensive Agents; Bile Acids and Salts; Humans; Hypertension; Liver; Rats; Taurine | 2023 |
Taurine Regulation of Peripheral Hemodynamics.
Topics: Animals; Blood Pressure; Female; Hemodynamics; Hypertension; Male; Rats; Sex Factors; Tachycardia; T | 2019 |
Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Inda | 2021 |
Taurine enhances spermatogenic function and antioxidant defense mechanisms in testes and epididymis of L-NAME-induced hypertensive rats.
Topics: Animals; Antioxidants; Epididymis; Hypertension; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Wi | 2018 |
Taurine Ameliorates Thyroid Hypofunction and Renal Injury in L-NAME-Induced Hypertensive Rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Dietary Supplements; Disease Models, Ani | 2019 |
Effects of Taurine on Blood Index of Hypothalamic Pituitary Adrenal (HPA) Axis of Stress-Induced Hypertensive Rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Health Status Indicators; Hype | 2015 |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats.
Topics: Anabolic Agents; Animals; Blood Pressure; Hypertension; Male; Nandrolone; Nandrolone Decanoate; Nitr | 2016 |
Aminomethylpiperazines as selective urotensin antagonists.
Topics: Acamprosate; Animals; Aorta; Chemistry, Pharmaceutical; Drug Design; Humans; Hypertension; Models, C | 2008 |
Antihypertensive effect of taurine in rat.
Topics: Angiotensins; Animals; Antihypertensive Agents; Cytokines; Hypertension; Male; Malondialdehyde; Nitr | 2009 |
Perinatal taurine depletion increases susceptibility to adult sugar-induced hypertension in rats.
Topics: Animals; Dietary Carbohydrates; Disease Susceptibility; Female; Glucose; Hypertension; Pregnancy; Ra | 2009 |
LC-NMR identification of a novel taurine-related metabolite observed in (1)H NMR-based metabonomics of genetically hypertensive rats.
Topics: Animals; Chromatography, Liquid; Disease Models, Animal; Hypertension; Magnetic Resonance Spectrosco | 2010 |
Perinatal micronutrient supplements ameliorate hypertension and proteinuria in adult fawn-hooded hypertensive rats.
Topics: Animals; Arginine; Ascorbic Acid; Blood Pressure; Dietary Supplements; Female; Hypertension; Kidney | 2010 |
Taurine prevents hypertension and increases exercise capacity in rats with fructose-induced hypertension.
Topics: Animals; Blood Glucose; Creatine Kinase; Electrolytes; Fructose; Glutathione; Hypertension; Insulin; | 2011 |
A metabonomic study of biochemical changes characteristic of genetically hypertensive rats based on (1)H NMR spectroscopic urinalysis.
Topics: Animals; Citric Acid; Creatine; Disease Progression; Hippurates; Hypertension; Magnetic Resonance Sp | 2012 |
Synergistic effects of taurine and L-arginine on attenuating insulin resistance hypertension.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Cyclic GMP; Drug Synergis | 2013 |
Effects of taurine and enalapril on kidney function of the hypertensive glucose-intolerant rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Body W | 2003 |
[INVESTIGATIONS ON THE EXCHANGE OF FREE AMINO ACIDS AND UREA BETWEEN BLOOD AND CENTRAL NERVOUS SYSTEM].
Topics: Amino Acids; Blood; Brain; Bronchial Neoplasms; Central Nervous System; Cerebrovascular Circulation; | 1964 |
Oral taurine supplementation prevents fructose-induced hypertension in rats.
Topics: Animals; Blood Pressure; Calcium; Fructose; Hypertension; Male; Rats; Rats, Sprague-Dawley; Taurine | 2004 |
Hoe 140 abolishes the blood pressure lowering effect of taurine in high fructose-fed rats.
Topics: Administration, Oral; Animals; Blood Pressure; Body Weight; Bradykinin; Disease Models, Animal; Fruc | 2004 |
Worldwide epidemic of obesity: hope for Japanese diets.
Topics: Animals; Asian People; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diet; | 2004 |
Investigations into biochemical changes of genetic hypertensive rats using 1H nuclear magnetic resonance-based metabonomics.
Topics: Animals; Citric Acid; Creatine; Creatinine; Dimethylamines; Disease Models, Animal; Hypertension; Ke | 2005 |
Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
Topics: Animals; Blood Pressure; Body Weight; Catalase; Cyclosporine; Glutathione; Glutathione Peroxidase; H | 2006 |
Effects of dietary salt and fat on taurine excretion in healthy and diseased rats.
Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Dietary Fats; Female; Glucose; Hypertensio | 2006 |
The antihypertensive effect of taurine in DOCA-salt rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Drug Evaluation, Preclinical | 1984 |
Taurine content of cardiac tissue in spontaneously hypertensive rats.
Topics: Age Factors; Animals; Female; Hypertension; Male; Myocardium; Rats; Rats, Inbred Strains; Taurine | 1983 |
[Pathophysiology of hypertension. e. Essential hypertension and platelet functions].
Topics: Adult; beta-Thromboglobulin; Humans; Hypertension; Middle Aged; Platelet Adhesiveness; Platelet Aggr | 1984 |
Nutritional factors and cardiovascular disease.
Topics: Animals; Brain; Cardiovascular Diseases; Cerebrovascular Disorders; Diet; Dietary Proteins; Food Ana | 1984 |
Alteration of cerebral taurine biosynthesis in spontaneously hypertensive rats.
Topics: Animals; Brain; Carbon Radioisotopes; Cerebral Cortex; Cysteine; Cysteine Dioxygenase; Dioxygenases; | 1984 |
beta-Alanine and alpha-L-alanine inhibit the exploratory activity of spontaneously hypertensive rats.
Topics: Alanine; Animals; beta-Alanine; Blood Platelets; Brain; Exploratory Behavior; Heart; Hypertension; L | 1982 |
Decrease of urinary taurine in essential hypertension.
Topics: Adult; Blood Pressure; Creatinine; Humans; Hypertension; Lipoproteins, HDL; Middle Aged; Taurine | 1983 |
Decreased urinary taurine in essential hypertension.
Topics: Adult; Blood Pressure; Creatinine; Humans; Hypertension; Metabolic Clearance Rate; Middle Aged; Taur | 1983 |
Platelet taurine in patients with arterial hypertension, myocardial failure or infarction.
Topics: Aged; Blood Platelets; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial In | 1980 |
Taurine diet decreases spontaneous and increases exploratory activity of spontaneously hypertensive rats.
Topics: Animals; Behavior, Animal; Brain; Diet; Exploratory Behavior; Hypertension; Male; Rats; Rats, Inbred | 1982 |
Antihypertensive effect of taurine on salt-induced hypertension.
Topics: Animals; Blood Pressure; Brain; Hexamethonium; Hypertension; Hypothalamus; Injections, Intraventricu | 1994 |
Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
Topics: Animals; beta-Alanine; Blood Pressure; Bradykinin; Gene Expression; Hypertension; Kallikreins; Kidne | 1994 |
Antihypertensive mechanism of exercise.
Topics: Atrial Natriuretic Factor; Blood Pressure; Cardenolides; Cardiac Output; Digoxin; Dopamine; Exercise | 1993 |
Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Bile Acids and Salts; Body Weight; Cerebrovascular Disorders; Cholesterol; Cholesterol 7-al | 1996 |
Effects of taurine on calcium in platelets and their aggregation.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Calcium; Coronary Disease; Cytosol; Female; Humans; H | 1996 |
Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance.
Topics: Animals; Blood Glucose; Blood Pressure; Creatinine; Disease Models, Animal; Fructose; Glucose Tolera | 1999 |
Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats.
Topics: Acetaldehyde; Administration, Oral; Animals; Blood Platelets; Blood Pressure; Body Weight; Calcium; | 2000 |
Comparative studies of diet-related factors and blood pressure among Chinese and Japanese: results from the China-Japan Cooperative Research of the WHO-CARDIAC Study. Cardiovascular Disease and Alimentary Comparison.
Topics: Blood Pressure; Body Mass Index; Calcium; China; Cholesterol; Creatinine; Cross-Cultural Comparison; | 2000 |
Effects of high salt diets and taurine on the development of hypertension in the stroke-prone spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Hypertension; Male; Rats; Rats, Inbred SHR; Sodium Chloride, Dietary; Tauri | 2000 |
Changes in taurine concentration in heart and skeletal muscle during atrophy and hypertrophy.
Topics: Amino Acids; Animals; Atrophy; Cardiomegaly; Hypertension; Hypertrophy; Isoproterenol; Male; Muscle | 1975 |
Dietary effect on central blood pressure regulation [proceedings].
Topics: Animals; Blood Pressure; Cerebrovascular Disorders; Cysteine; Dietary Proteins; Hypertension; Methio | 1979 |
Prophylactic trials for stroke in stroke-prone SHR. (4) Mechanism of prevention by dietary protein [proceedings].
Topics: Animals; Aorta; Blood Pressure; Cerebrovascular Disorders; Dietary Proteins; Elasticity; Hypertensio | 1979 |
Hypertension and atherogenesis in animal models - a new aspect on the relationship [proceedings].
Topics: Animals; Arteriosclerosis; Blood Pressure; Cerebrovascular Disorders; Cholesterol; Disease Models, A | 1979 |
Effect of dietary taurine on blood pressure in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Cerebrovascular Disorders; Diet; Hypertension; Liver; Male; Rats; Taurine; | 1978 |
[The Martorell ischemic hypertensive leg ulcer].
Topics: Aged; Female; Humans; Hypertension; Ischemia; Leg; Leg Ulcer; Secologanin Tryptamine Alkaloids; Synd | 1977 |
Excitatory and inhibitory amino acid changes in ischemic brain regions in spontaneously hypertensive rats.
Topics: Amino Acids; Animals; Aspartic Acid; Brain; Cerebral Cortex; Corpus Striatum; gamma-Aminobutyric Aci | 1991 |
Hypotensive action of taurine in DOCA-salt rats--involvement of sympathoadrenal inhibition and endogenous opiate.
Topics: Adrenal Glands; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Heart Rate; | 1991 |
[Taurine metabolism in platelets in patients with pregnancy induced hypertension].
Topics: Blood Platelets; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Ca | 1990 |
Altered amino acid levels in brainstem regions of spontaneously hypertensive rats.
Topics: Amino Acids; Animals; beta-Alanine; Brain Stem; Chromatography, High Pressure Liquid; gamma-Aminobut | 1989 |
Changes in serum concentrations of taurine and other amino acids in clinical antihypertensive exercise therapy.
Topics: Adult; Amino Acids; Blood Pressure; Blood Volume; Creatine Kinase; Exercise Therapy; Female; gamma-G | 1989 |
Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
Topics: Animals; Blood Pressure; Cold Temperature; Desoxycorticosterone; Hexamethonium; Hexamethonium Compou | 1987 |
Retardation of the development of hypertension in DOCA salt rats by taurine supplement.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Depression, Chemical; Desoxycorticosterone; Epinephri | 1988 |
Influence of endogenous opiates on the hypotensive action of taurine in DOCA-salt rats.
Topics: Animals; Desoxycorticosterone; Endorphins; Hypertension; Male; Naloxone; Rats; Rats, Inbred Strains; | 1988 |
Inhibition of hypertension and salt intake by oral taurine treatment in hypertensive rats.
Topics: Administration, Oral; Angiotensin II; Animals; Drinking; Hypertension; Male; Rats; Rats, Inbred SHR; | 1987 |
Effects of sulphur amino acids on the development of hypertension and atherosclerosis in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Arteriosclerosis; Cerebrovascular Disorders; Cholesterol; Cholesterol, Dietary; Cholesterol | 1987 |
Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Extracellular Space; Hypertension; Male; Rats; Rats, | 1986 |
Feasibility of overnight urine for assessing dietary intakes of sodium, potassium, protein and sulfur amino acids in field studies.
Topics: Adult; Amino Acids, Sulfur; Dietary Proteins; Female; Humans; Hypertension; Male; Middle Aged; Potas | 1986 |
Hypotensive responses to centrally administered taurine in DOCA-salt hypertensive and spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Heart Rate; Hypertension; Injections, Intraventricula | 1986 |
Decrease of plasma sulfur amino acids in essential hypertension.
Topics: Adult; Aged; Amino Acids, Sulfur; Blood Pressure; Female; Humans; Hypertension; Male; Methionine; Mi | 1985 |
Blood platelets: accumulation and release of taurine.
Topics: Animals; Biological Transport, Active; Blood Platelets; Heart Failure; Humans; Hypertension; In Vitr | 1985 |
Alteration of cerebral biosynthesis of taurine in spontaneously hypertensive and 3-acetylpyridine intoxicated rats.
Topics: Animals; Brain; Carboxy-Lyases; Cystamine; Cysteic Acid; Cysteine; Cysteine Dioxygenase; Dioxygenase | 1985 |
Taurine concentrations in congestive heart failure.
Topics: Aged; Aging; Animals; Aorta; Brain Chemistry; Female; Heart Failure; Humans; Hypertension; Male; Mid | 1974 |
[Action of a taurine-nucleotide-vitamin association on carbohydrate metabolism].
Topics: Adult; Aged; Arteriosclerosis; Biliary Tract Diseases; Carbohydrate Metabolism; Coronary Disease; Di | 1971 |
[Use in geriatrics of an association of taurine, nucleotides and vitamins].
Topics: Adult; Aged; Arteriosclerosis; Cerebrovascular Disorders; Dementia; Female; Hemiplegia; Humans; Hype | 1970 |